Vivos Therapeutics swaps $2.86M Streeterville notes for up to 11.45M shares

Vivos Therapeutics entered twelve exchange agreements effective Aug 31, 2026 to convert $2,861,270 of partitioned Streeterville notes into up to 11,445,080 common shares at prices at or above Nasdaq minimums.